CMPX – compass therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its price target raised by analysts at HC Wainwright from $10.00 to $24.00. They now have a "buy" rating on the stock.
Compass Therapeutics, Inc. (NASDAQ: CMPX) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
Compass Therapeutics And 2 More Compelling Penny Stocks [Yahoo! Finance]
Form 8-K Compass Therapeutics, For: Apr 01
Form S-8 Compass Therapeutics,
Form 10-K Compass Therapeutics, For: Dec 31
Form 8-K Compass Therapeutics, For: Feb 27
Form SCHEDULE 13G Compass Therapeutics, Filed by: MPM BioImpact LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.